Filing Details
- Accession Number:
- 0001062993-12-003638
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-17 16:40:58
- Reporting Period:
- 2012-09-13
- Filing Date:
- 2012-09-17
- Accepted Time:
- 2012-09-17 16:40:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1369868 | China Biologic Products Inc. | CBPO | Biological Products, (No Disgnostic Substances) (2836) | 752308816 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1331795 | David Gao | 18Th Floor, Jialong Int'L Building, 19 Chaoyang Park Road Beijing F4 100125 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-09-13 | 5,000 | $8.93 | 12,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in the open market at prices ranging from $8.89 to $9.00, inclusive. The Reporting Person undertakes to provide to any securityholders of China Biologic Products, Inc. (the "Issuer") or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.